APA (7th ed.) Citation

Lee, M. S., Chao, J., Mulcahy, M. F., Kasi, P. M., Alistar, A. T., Mukherjee, S., . . . Somasundaram, A. (2025). Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma. The oncologist (Dayton, Ohio), 30(7), . https://doi.org/10.1093/oncolo/oyaf195

Chicago Style (17th ed.) Citation

Lee, Michael S., et al. "Phase II Study of Avelumab and Trastuzumab with FOLFOX Chemotherapy in Previously Untreated HER2-amplified Metastatic Gastroesophageal Adenocarcinoma." The Oncologist (Dayton, Ohio) 30, no. 7 (2025). https://doi.org/10.1093/oncolo/oyaf195.

MLA (9th ed.) Citation

Lee, Michael S., et al. "Phase II Study of Avelumab and Trastuzumab with FOLFOX Chemotherapy in Previously Untreated HER2-amplified Metastatic Gastroesophageal Adenocarcinoma." The Oncologist (Dayton, Ohio), vol. 30, no. 7, 2025, https://doi.org/10.1093/oncolo/oyaf195.